@article{1c50e04e0e50417c8142030fa22dc1a7,
title = "Low-Dose Bevacizumab - But What about Long-term Results?",
author = "Harper, {C. Armitage} and Beck, {Kinley D.} and Moshfeghi, {Darius M.}",
note = "Funding Information: Conflict of Interest Disclosures: Dr Wallace reported grants from the National Eye Institute. Dr Kraker reported grants from the National Institutes of Health and the National Eye Institute as coordinating center for the Pediatric Eye Disease Investigator Group. Funding Information: ConflictofInterestDisclosures:DrHarperreportedpersonalfeesfromRegeneron. Dr Moshfeghi reported personal fees from Bayer, Novartis, Akebia, and Regeneron, as well as grants from Genentech. No other disclosures were reported.",
year = "2022",
month = mar,
doi = "10.1001/jamaophthalmol.2021.5864",
language = "English (US)",
volume = "140",
pages = "287--288",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "3",
}